NYSE - Delayed Quote USD

Globus Medical, Inc. (GMED)

Compare
70.64 +0.04 (+0.06%)
At close: September 20 at 4:00 PM EDT
71.15 +0.51 (+0.72%)
After hours: September 20 at 6:59 PM EDT
Loading Chart for GMED
DELL
  • Previous Close 70.60
  • Open 70.38
  • Bid 69.37 x 800
  • Ask 73.50 x 800
  • Day's Range 69.80 - 70.70
  • 52 Week Range 43.39 - 74.21
  • Volume 611,292
  • Avg. Volume 866,744
  • Market Cap (intraday) 9.565B
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) 353.20
  • EPS (TTM) 0.20
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 79.31

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

www.globusmedical.com

5,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GMED

View More

Performance Overview: GMED

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GMED
32.56%
S&P 500
19.55%

1-Year Return

GMED
32.76%
S&P 500
28.32%

3-Year Return

GMED
12.49%
S&P 500
28.64%

5-Year Return

GMED
37.57%
S&P 500
89.66%

Compare To: GMED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GMED

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    9.57B

  • Enterprise Value

    9.60B

  • Trailing P/E

    353.20

  • Forward P/E

    20.92

  • PEG Ratio (5yr expected)

    1.90

  • Price/Sales (ttm)

    4.17

  • Price/Book (mrq)

    2.41

  • Enterprise Value/Revenue

    4.29

  • Enterprise Value/EBITDA

    24.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.82%

  • Return on Assets (ttm)

    6.11%

  • Return on Equity (ttm)

    1.37%

  • Revenue (ttm)

    2.24B

  • Net Income Avi to Common (ttm)

    40.67M

  • Diluted EPS (ttm)

    0.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    492.93M

  • Total Debt/Equity (mrq)

    13.35%

  • Levered Free Cash Flow (ttm)

    -227.96M

Research Analysis: GMED

View More

Company Insights: GMED

Research Reports: GMED

View More

People Also Watch